P413L CHGB is not associated with ALS susceptibility or age at onset in a Dutch population.
作者信息
van Vught Paul W J, Veldink Jan H, van den Berg Leonard H
出版信息
Proc Natl Acad Sci U S A. 2010 May 11;107(19):E77; author reply E78. doi: 10.1073/pnas.1002512107. Epub 2010 Apr 29.
Abstract
摘要
相似文献
1
P413L CHGB is not associated with ALS susceptibility or age at onset in a Dutch population.
Proc Natl Acad Sci U S A. 2010 May 11;107(19):E77; author reply E78. doi: 10.1073/pnas.1002512107. Epub 2010 Apr 29.
2
Lack of relationship between the P413L chromogranin B variant and a SALS Italian cohort.
Gene. 2015 Sep 1;568(2):186-9. doi: 10.1016/j.gene.2015.05.040. Epub 2015 May 19.
3
Lack of association between the P413L variant of chromogranin B and ALS risk or age at onset: a meta-analysis.
Amyotroph Lateral Scler Frontotemporal Degener. 2018 Feb;19(1-2):80-86. doi: 10.1080/21678421.2017.1361444. Epub 2017 Aug 10.
4
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21777-82. doi: 10.1073/pnas.0902174106. Epub 2009 Dec 9.
5
The P413L chromogranin B variation in French patients with sporadic amyotrophic lateral sclerosis.
Amyotroph Lateral Scler. 2011 May;12(3):210-4. doi: 10.3109/17482968.2010.522587. Epub 2010 Oct 11.
6
Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort.
Genes (Basel). 2024 Sep 12;15(9):1197. doi: 10.3390/genes15091197.
7
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.
Hum Mol Genet. 2016 Nov 1;25(21):4771-4786. doi: 10.1093/hmg/ddw304.
8
Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients.
Neurobiol Aging. 2012 Aug;33(8):1845.e1-3. doi: 10.1016/j.neurobiolaging.2012.01.007. Epub 2012 Feb 11.
9
Novel optineurin mutations in sporadic amyotrophic lateral sclerosis patients.
Neurobiol Aging. 2012 May;33(5):1016.e1-7. doi: 10.1016/j.neurobiolaging.2011.05.019. Epub 2011 Jul 28.
10
Second-generation Irish genome-wide association study for amyotrophic lateral sclerosis.
Neurobiol Aging. 2015 Feb;36(2):1221.e7-13. doi: 10.1016/j.neurobiolaging.2014.08.030. Epub 2014 Sep 6.
引用本文的文献
1
Peptidomic analysis of CSF reveals new biomarker candidates for amyotrophic lateral sclerosis.
EMBO Mol Med. 2025 Jul 18. doi: 10.1038/s44321-025-00272-w.
2
Genome-Wide DNA Methylation and Hydroxymethylation Changes Revealed Epigenetic Regulation of Neuromodulation and Myelination in Yak Hypothalamus.
Front Genet. 2021 Sep 27;12:592135. doi: 10.3389/fgene.2021.592135. eCollection 2021.
3
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.
Hum Mol Genet. 2016 Nov 1;25(21):4771-4786. doi: 10.1093/hmg/ddw304.
本文引用的文献
1
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.
Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21777-82. doi: 10.1073/pnas.0902174106. Epub 2009 Dec 9.
2
Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis.
J Neurol Neurosurg Psychiatry. 2010 May;81(5):562-6. doi: 10.1136/jnnp.2009.181453. Epub 2009 Dec 3.
3
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis.
Nat Genet. 2009 Oct;41(10):1083-7. doi: 10.1038/ng.442. Epub 2009 Sep 6.
4
Why most discovered true associations are inflated.
Epidemiology. 2008 Sep;19(5):640-8. doi: 10.1097/EDE.0b013e31818131e7.
5
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1977-81. doi: 10.1073/pnas.90.5.1977.
Zotero 插件